Q2 2022 Agios Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Agios Second Quarter 2022 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Agios' request. I would now like to turn the conference over to Holly Manning, Senior Director of Investor Relations. Please go ahead.
Thank you, operator. Good morning, everyone, and welcome to Agios' Second Quarter 2022 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com. With me on the call today with prepared remarks are Dr. Jackie Fouse, our Chief Executive Officer; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; Richa Poddar, our Chief Commercial Officer; and Jonathan Biller, our Chief Financial Officer and Head of Corporate Affairs.
Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |